socalTECH

AUGUST 2, 2017

Our interview today is with Alan Horsager , the CEO of Pasadena-based Episona (www.episona.com), an angel backed startup which has already developed and has been offering up an epigenetic test for male fertility. Where was the technology for this developed? The onus for us is really about the technical validation of the assay.

USC 100

USC Technical Review Startup Southern California 100

socalTECH

OCTOBER 1, 2008

A study of the venture capital deal flow in Southern California conducted by socalTECH shows that venture capital deals dropped for Q3, to around $720M in deals, in a market dominated by clean technology firms. in venture capital deals in the third quarter, down dramatically from $1.2B

Southern California 100

Southern California SoCalTech Technical Review Draper 100

Xconomy

NOVEMBER 11, 2016

—Xconomy rounded up some post-election thoughts from several local tech and life science leaders , which included a mix of outrage, resiliency, hope, rationalizing, grandstanding, and some calls for calm and reason. The Nitto drug is in a Phase 1b study. Bagger is helping run the transition. CRISPR DEVELOPMENTS. 6 at the U.S.

Patents 87

Patents Study Pricing Research 87

Both Sides of the Table

AUGUST 14, 2009

I know you’re not a tech guy and haven’t done anything other than an HTML course you once took, but if you’re inspirational and a leader you’ll find somebody to moonlight for free to get your prototype built. If you can’t get product released and validated then do user studies. That’s OK.

Angel 291

Angel Funding Venture Capital Startup 291